By Laura R. Bobolts, PharmD, BCOP, Senior Vice President, Clinical Strategy and Growth at OncoHealth Key Takeaways New oncology treatments presented at ASCO are rapidly heading for FDA approval Payers need to be prepared to assess which off-label treatments presented...
